217
Participants
Start Date
January 31, 2006
Primary Completion Date
March 31, 2007
Study Completion Date
May 31, 2007
Sevelamer carbonate (Renvela®)
sevelamer carbonate powder dosed once per day with largest meal
Sevelamer hydrochloride (Renagel®)
Sevelamer hydrochloride tablets dosed three times a day with meals
Davita, The Bronx
Winthrop University Dialysis Center, Mineola
Lewiston Dialysis Center, Lewistown
Gambro Healthcare - Charlottesville, Charlottesville
Virginia Commonwealth University, Division of Nephrology, Richmond
Clinical Research of Tidewater, Norfolk
Atlanta Nephrology Referral Center, Decatur
FMC Marietta, Marietta
Central Dialysis Center, Atlanta
Crystal Rivers Dialysis Center, Crystal River
Outcomes Research International, Inc., Hudson
Clinical Research Center, Birmingham
Gadsden Dialysis, Gadsden
Nephrology Associates, P.C., Nashville
Medical Nephrology Associates, Dyersburg
Nephrology & Hypertension Associates, LTD, Tupelo
Southwest Mississippi Nephrology, PLLC, Brookhaven
Nephrology Associates, P.C., Columbus
Renal Care Group, Cleveland
Kidney and Hypertension Center, Cincinnati
Indiana University Hospital, Indianapolis
Henry Ford Hospital, Detroit
Horizon Healthcare Associates, Flossmoor
Washington University School of Medicine, St Louis
Ochsner Clinic Foundation, Nephrology Research, New Orleans
Renal Research Inc. at the Kidney Institute, Houston
Holy Cross Renal Care, Mission Hills
Nephrology Educational Services and Research, Tarzana
Hypertension and Nephrology Associates, Eatontown
Genzyme, a Sanofi Company
INDUSTRY